| Recruiting | A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft F NCT07020832 | Apellis Pharmaceuticals, Inc. | Phase 3 |
| Recruiting | The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients NCT07275632 | First Affiliated Hospital of Chongqing Medical University | Phase 1 / Phase 2 |
| Recruiting | Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravuliz NCT06830798 | Alexion Pharmaceuticals, Inc. | Phase 3 |
| Recruiting | Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation NCT06855758 | Beijing Friendship Hospital | N/A |
| Recruiting | Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantatio NCT06367205 | RenJi Hospital | N/A |
| Active Not Recruiting | ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function NCT05907096 | argenx | Phase 2 |
| Completed | Study of the Correlation Between Donor CIRBP and Transplanted Kidney Function NCT06641622 | Third Affiliated Hospital, Sun Yat-Sen University | — |
| Unknown | Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation NCT05166460 | Thomas Skinner | N/A |
| Completed | Graft Acute Kidney Injury: Vitamin B3 to Facilitate Renal Recovery In the Early Life of a Transplant NCT05513807 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Recruiting | Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys NCT05430620 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Phase 3 |
| Recruiting | Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transpl NCT04005469 | Rhode Island Hospital | Phase 1 / Phase 2 |
| Completed | Envarsus in Delayed Graft Function (E-DGF) NCT03864926 | University of Wisconsin, Madison | Phase 4 |
| Completed | Renaparin® in Kidney Transplantation NCT03773211 | Corline Biomedical AB | Phase 1 |
| Completed | Better Evidence for Selecting Transplant Fluids NCT03829488 | The University of Queensland | Phase 3 |
| Completed | Deceased Organ Donor Interventions to Protect Kidney Graft Function NCT02525510 | University of California, San Francisco | N/A |
| Completed | Volatile Anesthetic Protection Of Renal Transplants 2 NCT02727296 | University Medical Center Groningen | Phase 4 |
| Recruiting | Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation NCT03071536 | King Chulalongkorn Memorial Hospital | N/A |
| Withdrawn | Delayed Renal Allograft Function and Furosemide Treatment NCT02312115 | Loma Linda University | Phase 2 |
| Completed | QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant NCT02610296 | Quark Pharmaceuticals | Phase 3 |
| Unknown | Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney NCT02474667 | Angion Biomedica Corp | Phase 3 |
| Unknown | Prediction and Management of Delayed Graft Function Based on Donor Criteria and LifePort Platform NCT02876692 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Completed | The Frequency and Risk Factors of Delayed Graft Function NCT03555513 | nooshin dalili | — |
| Completed | Propensity Score Matched Comparison of HMP vs. SCS in Kidney Transplantation NCT04359173 | Medical University Innsbruck | — |
| Unknown | Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft Function NCT02568696 | Helsinki University Central Hospital | — |
| Unknown | A Study of Retrograde rEperfusion in Dbd Donor LIver Transplantation NCT02423941 | Republican Scientific and Practical Center for Organ and Tissue Transplantation | N/A |
| Completed | Correlation of Molecular Biomarkers With Biopsy Findings and Outcomes in Renal Transplant Recipients NCT02463253 | University of California, Davis | — |
| Completed | Biomarkers of Aging as Predictors of Kidney Transplant Function NCT02335333 | Sapere Bio | — |
| Completed | Evaluation of CAF22 After Renal Transplantation NCT02346968 | Insel Gruppe AG, University Hospital Bern | — |
| Completed | C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI NCT02134314 | Cedars-Sinai Medical Center | Phase 1 / Phase 2 |
| Completed | Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study) NCT02145182 | Alexion Pharmaceuticals, Inc. | Phase 2 / Phase 3 |
| Unknown | Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy NCT02240823 | Martha Haahr M.D | Phase 1 |
| Terminated | Belatacept for Renal Transplant Recipients With Delayed Graft Function NCT02134288 | Ohio State University | EARLY_Phase 1 |
| Terminated | Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation NCT01919346 | Heeger, Peter, M.D. | Phase 2 |
| Unknown | Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function NCT01837043 | Nair, Vinay, D.O. | Phase 2 |
| Terminated | A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Ki NCT01878786 | Matthew Cooper | Phase 2 / Phase 3 |
| No Longer Available | CliniMACS® CD34+ Reagent System for Expanded Access Use NCT02026934 | Joseph Antin | — |
| Completed | Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Func NCT01794663 | Opsona Therapeutics Ltd. | Phase 2 |
| Unknown | Study on Delayed Graft Function Using Paired Kidneys NCT01561599 | Angion Biomedica Corp | Phase 2 |
| Unknown | Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graf NCT01395719 | University of Aarhus | N/A |
| Unknown | Role of T Helper 17 and Regulatory T Cells in Delayed Graft Function NCT01232816 | McGill University Health Centre/Research Institute of the McGill University Health Centre | — |
| Completed | Deceased Donor Biomarkers and Recipient Outcomes NCT01848249 | Yale University | — |
| Unknown | Study to Improve Renal Function After Kidney Transplantation NCT01286727 | Angion Biomedica Corp | Phase 2 |
| Terminated | Tacrolimus to Sirolimus Conversion for Delayed Graft Function NCT00931255 | University of Maryland, Baltimore | Phase 4 |
| Completed | I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation NCT00802347 | Quark Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantati NCT00425126 | West Penn Allegheny Health System | Phase 4 |
| Completed | YSPSL for Prevention of Delayed Graft Function Part A NCT00298181 | Y's Therapeutics, Inc. | — |
| Terminated | A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of Cell NCT00217152 | Mayo Clinic | Phase 4 |
| Completed | Comparison of Sirolimus and Azathioprine in Lung Transplantation NCT00321906 | University of Chicago | Phase 4 |